TNGX
Tango Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -30.0% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 96 | +22 | 90.50M | $2.83B | +24 | −2 |
| Q1 2026 | 77 | 0 | 72.21M | $1.51B | +9 | −9 |
| Q4 2025 | 76 | 0 | 64.83M | $574.42M | +1 | −1 |
| Q3 2025 | 19 | +2 | 27.21M | $228.58M | +3 | −1 |
| Q2 2025 | 14 | 0 | 22.55M | $115.47M | +1 | −1 |
| Q1 2025 | 11 | +1 | 6.63M | $9.09M | +2 | −1 |
| Q4 2024 | 10 | 0 | 4.99M | $15.42M | +3 | −3 |
| Q3 2024 | 9 | -1 | 6.83M | $52.57M | +1 | −2 |
| Q2 2024 | 10 | — | 5.64M | $48.44M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.63M | -39.6% | $5.03M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | Geode Capital Management ✦ (pasivo) | 1.39M | +1.3% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.39M | +1.3% | $4.29M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 1.23M | — | $3.80M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 249.65K | Nuevo | $771,406 | 0.0% | New | 1 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 154.95K | 0.0% | $478,786 | 0.0% | Held | 3 | SEC ↗ |
| 7 | Wellington Management ✦ | 138.25K | -3.5% | $427,183 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 138.25K | -3.5% | $427,183 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 114.83K | Nuevo | $354,815 | 0.0% | New | 1 | SEC ↗ |
| 10 | D. E. Shaw & Co. ✦ | 114.83K | Nuevo | $354,815 | 0.0% | New | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 45.00K | -34.0% | $139,038 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 21.50K | Nuevo | $66,435 | 0.0% | New | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 21.00K | +29.7% | $65,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Millennium Management | $771,406 | 0.0% |
| D. E. Shaw & Co. | $354,815 | 0.0% |
| D. E. Shaw & Co. | $354,815 | 0.0% |
| Renaissance Technologies | $66,435 | 0.0% |
Posición cerrada
| Adage Capital Partners | $17.67M | era 0.0% |
| Marshall Wace | $563,040 | era 0.0% |
| AQR Capital Management | $109,386 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 193 tenedores, 180.17M acciones, $3.72B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.